ThinkEquity acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics announces common stock offering, no amount given
- Intensity Therapeutics reports data from Invincible-4 study
- Intensity Therapeutics Faces Nasdaq Delisting Notice
- Intensity Therapeutics price target lowered to $3.50 from $8.50 at Alliance Global Partners
- Intensity Therapeutics Faces Nasdaq Non-Compliance Notice